ScholarIQanswers from OpenAlex & ORCID
Julia Kuder
ResearcherPublications, citations & collaboration network
Julia Kuder is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Julia Kuder have?
ScholarIQindexed works
Julia Kuder has 103 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Julia Kuder have?
ScholarIQcitation count
Julia Kuder has 21,326 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Julia Kuder?
ScholarIQh-index
Julia Kuder has an h-index of 42 in OpenAlex.
What is the i10-index of Julia Kuder?
ScholarIQi10-index
Julia Kuder has an i10-index of 60 in OpenAlex.
What is the ORCID of Julia Kuder?
ScholarIQorcid
The ORCID for Julia Kuder is on the source record.
What is the OpenAlex record for Julia Kuder?
ScholarIQopenalex
The OpenAlex for Julia Kuder is on the source record.
What are the most-cited papers on Julia Kuder?
ScholarIQmost cited works
Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes
Stephen D. Wiviott, Itamar Raz, Marc P. Bonaca, Ofri Mosenzon, Eri Kato, Avivit Cahn, Michael G. Silverman, Thomas A. Zelniker, Julia Kuder, Sabina A. Murphy, Deepak L. Bhatt, Lawrence A. Leiter, Darren K. McGuire, John Wilding, Christian T. Ruff, Ingrid Gause‐Nilsson, Martin Fredriksson, Peter A. Johansson, Anna-Maria Langkilde, Marc S. Sabatine
Evolocumab and Clinical Outcomes in Patients with Cardiovascular Disease
Marc S. Sabatine, Robert P. Giugliano, Anthony Keech, Narimon Honarpour, Stephen D. Wiviott, Sabina A. Murphy, Julia Kuder, Huei Wang, Thomas Liu, Scott M. Wasserman, Peter Sever, Terje R. Pedersen
Cardiovascular safety and efficacy of the PCSK9 inhibitor evolocumab in patients with and without diabetes and the effect of evolocumab on glycaemia and risk of new-onset diabetes: a prespecified analysis of the FOURIER randomised controlled trial
Marc S. Sabatine, Lawrence A. Leiter, Stephen D. Wiviott, Robert P. Giugliano, Prakash Deedwania, Gaetano Maria De Ferrari, Sabina A. Murphy, Julia Kuder, Ioanna Gouni‐Berthold, Basil S. Lewis, Yehuda Handelsman, Armando Lira Pineda, Narimon Honarpour, Anthony Keech, Peter S. Sever, Terje R. Pedersen
Effect of Dapagliflozin on Heart Failure and Mortality in Type 2 Diabetes Mellitus
Eri Kato, Michael G. Silverman, Ofri Mosenzon, Thomas A. Zelniker, Avivit Cahn, Remo H.M. Furtado, Julia Kuder, Sabina A. Murphy, Deepak L. Bhatt, Lawrence A. Leiter, Darren K. McGuire, John Wilding, Marc P. Bonaca, Christian T. Ruff, Akshay S. Desai, Shinya Goto, Peter A. Johansson, Ingrid Gause‐Nilsson, Per Johanson, Anna Maria Langkilde, Itamar Raz, Marc S. Sabatine, Stephen D. Wiviott
Effect of Dapagliflozin on Atrial Fibrillation in Patients With Type 2 Diabetes Mellitus
Thomas A. Zelniker, Marc P. Bonaca, Remo H.M. Furtado, Ofri Mosenzon, Julia Kuder, Sabina A. Murphy, Deepak L. Bhatt, Lawrence A. Leiter, Darren K. McGuire, John Wilding, Andrzej Budaj, Róbert Gábor Kiss, Francisco Padilla, Ingrid Gause‐Nilsson, Anna Maria Langkilde, Itamar Raz, Marc S. Sabatine, Stephen D. Wiviott